| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Food Hypersensitivity | 35 | 2024 | 167 | 12.790 |
Why?
|
| Peanut Hypersensitivity | 15 | 2023 | 84 | 6.080 |
Why?
|
| Allergens | 24 | 2025 | 276 | 5.010 |
Why?
|
| Eosinophilic Esophagitis | 12 | 2021 | 79 | 3.880 |
Why?
|
| Desensitization, Immunologic | 14 | 2025 | 108 | 3.870 |
Why?
|
| Arachis | 11 | 2022 | 75 | 3.750 |
Why?
|
| Hypersensitivity | 7 | 2025 | 196 | 3.290 |
Why?
|
| Anaphylaxis | 8 | 2020 | 87 | 2.870 |
Why?
|
| Shellfish Hypersensitivity | 4 | 2020 | 5 | 2.390 |
Why?
|
| Epinephrine | 6 | 2023 | 155 | 2.240 |
Why?
|
| Immunoglobulin E | 10 | 2022 | 180 | 1.710 |
Why?
|
| Health Equity | 2 | 2024 | 75 | 1.420 |
Why?
|
| Immunotherapy | 4 | 2025 | 749 | 1.240 |
Why?
|
| T-Lymphocytes, Regulatory | 4 | 2021 | 234 | 1.130 |
Why?
|
| Eosinophilia | 2 | 2021 | 105 | 1.110 |
Why?
|
| Shellfish | 4 | 2020 | 31 | 1.090 |
Why?
|
| School Health Services | 2 | 2019 | 101 | 0.980 |
Why?
|
| Asthma | 4 | 2021 | 773 | 0.950 |
Why?
|
| Child, Preschool | 31 | 2021 | 14736 | 0.940 |
Why?
|
| Child | 41 | 2022 | 25783 | 0.940 |
Why?
|
| Humans | 79 | 2025 | 132238 | 0.930 |
Why?
|
| Dermatitis, Atopic | 2 | 2023 | 47 | 0.920 |
Why?
|
| School Nursing | 2 | 2014 | 9 | 0.870 |
Why?
|
| Administration, Oral | 8 | 2021 | 699 | 0.810 |
Why?
|
| Enterocolitis | 3 | 2019 | 29 | 0.800 |
Why?
|
| Healthcare Disparities | 2 | 2021 | 486 | 0.780 |
Why?
|
| Severe Combined Immunodeficiency | 3 | 2019 | 106 | 0.770 |
Why?
|
| Food | 3 | 2019 | 127 | 0.740 |
Why?
|
| Allergy and Immunology | 1 | 2022 | 30 | 0.740 |
Why?
|
| Dietary Proteins | 3 | 2019 | 219 | 0.740 |
Why?
|
| Genes, T-Cell Receptor gamma | 1 | 2021 | 3 | 0.720 |
Why?
|
| Rhinitis, Allergic | 1 | 2021 | 15 | 0.720 |
Why?
|
| Genes, T-Cell Receptor delta | 1 | 2021 | 8 | 0.720 |
Why?
|
| Emergency Medical Services | 2 | 2024 | 416 | 0.700 |
Why?
|
| Enteritis | 1 | 2021 | 52 | 0.690 |
Why?
|
| Adolescent | 28 | 2021 | 20556 | 0.690 |
Why?
|
| Skin Tests | 5 | 2019 | 80 | 0.670 |
Why?
|
| Schools | 3 | 2017 | 236 | 0.650 |
Why?
|
| Arthropod Proteins | 1 | 2019 | 12 | 0.630 |
Why?
|
| Gastroesophageal Reflux | 2 | 2016 | 338 | 0.620 |
Why?
|
| Venoms | 1 | 2019 | 19 | 0.610 |
Why?
|
| Breast Feeding | 2 | 2019 | 233 | 0.600 |
Why?
|
| Milk Hypersensitivity | 2 | 2021 | 13 | 0.590 |
Why?
|
| United States | 14 | 2024 | 11669 | 0.580 |
Why?
|
| Pasteurellaceae | 1 | 2018 | 4 | 0.580 |
Why?
|
| Clostridiaceae | 1 | 2018 | 5 | 0.580 |
Why?
|
| Actinomycetaceae | 1 | 2018 | 6 | 0.580 |
Why?
|
| Prevalence | 7 | 2020 | 2664 | 0.580 |
Why?
|
| Quality of Life | 9 | 2025 | 2161 | 0.570 |
Why?
|
| Gastritis | 1 | 2021 | 372 | 0.570 |
Why?
|
| Health Status Disparities | 1 | 2021 | 252 | 0.560 |
Why?
|
| Pollen | 2 | 2015 | 48 | 0.540 |
Why?
|
| Steroids | 1 | 2018 | 174 | 0.540 |
Why?
|
| Hypotension | 1 | 2019 | 185 | 0.530 |
Why?
|
| Cytomegalovirus Infections | 1 | 2019 | 224 | 0.520 |
Why?
|
| Nut and Peanut Hypersensitivity | 1 | 2016 | 2 | 0.520 |
Why?
|
| Sesamum | 1 | 2016 | 3 | 0.520 |
Why?
|
| Nut Hypersensitivity | 1 | 2016 | 7 | 0.520 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2018 | 394 | 0.510 |
Why?
|
| Infant | 18 | 2021 | 13049 | 0.510 |
Why?
|
| Esophageal Mucosa | 1 | 2016 | 12 | 0.500 |
Why?
|
| Diet Therapy | 4 | 2018 | 41 | 0.500 |
Why?
|
| Immunologic Deficiency Syndromes | 2 | 2016 | 216 | 0.490 |
Why?
|
| Galectin 3 | 1 | 2016 | 37 | 0.490 |
Why?
|
| Intubation, Intratracheal | 1 | 2019 | 288 | 0.480 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2019 | 466 | 0.460 |
Why?
|
| Health Services Accessibility | 1 | 2021 | 674 | 0.460 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 3 | 2019 | 1192 | 0.450 |
Why?
|
| Inservice Training | 1 | 2014 | 57 | 0.440 |
Why?
|
| Feces | 1 | 2018 | 753 | 0.440 |
Why?
|
| Milk | 2 | 2019 | 108 | 0.430 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2016 | 361 | 0.430 |
Why?
|
| Female | 34 | 2021 | 70780 | 0.420 |
Why?
|
| Granulomatous Disease, Chronic | 2 | 2020 | 70 | 0.420 |
Why?
|
| Fungi | 1 | 2014 | 76 | 0.420 |
Why?
|
| Male | 32 | 2021 | 65013 | 0.410 |
Why?
|
| Length of Stay | 1 | 2019 | 1382 | 0.400 |
Why?
|
| Drug Hypersensitivity | 2 | 2019 | 100 | 0.390 |
Why?
|
| Educational Status | 2 | 2024 | 294 | 0.380 |
Why?
|
| Faculty | 1 | 2013 | 104 | 0.380 |
Why?
|
| Diet | 3 | 2019 | 1125 | 0.370 |
Why?
|
| Practice Guidelines as Topic | 2 | 2017 | 1307 | 0.360 |
Why?
|
| Health Education | 1 | 2013 | 235 | 0.360 |
Why?
|
| Program Evaluation | 1 | 2013 | 456 | 0.350 |
Why?
|
| Animals | 13 | 2025 | 34845 | 0.340 |
Why?
|
| Parents | 1 | 2017 | 1080 | 0.330 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2018 | 810 | 0.330 |
Why?
|
| Adult | 12 | 2021 | 31614 | 0.330 |
Why?
|
| Cross Reactions | 3 | 2018 | 189 | 0.330 |
Why?
|
| Penaeidae | 1 | 2009 | 5 | 0.320 |
Why?
|
| Child Welfare | 1 | 2009 | 64 | 0.310 |
Why?
|
| Early Medical Intervention | 1 | 2019 | 30 | 0.300 |
Why?
|
| Esophagitis, Peptic | 1 | 2009 | 37 | 0.300 |
Why?
|
| Postnatal Care | 1 | 2019 | 52 | 0.300 |
Why?
|
| Antigens, Fungal | 1 | 2008 | 34 | 0.300 |
Why?
|
| Tetanus Toxoid | 1 | 2008 | 50 | 0.290 |
Why?
|
| Eosinophils | 1 | 2009 | 122 | 0.280 |
Why?
|
| DiGeorge Syndrome | 1 | 2008 | 82 | 0.280 |
Why?
|
| Candida | 1 | 2008 | 84 | 0.280 |
Why?
|
| Cultural Diversity | 2 | 2022 | 71 | 0.280 |
Why?
|
| Basidiomycota | 1 | 2007 | 12 | 0.270 |
Why?
|
| Canada | 2 | 2019 | 337 | 0.270 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2013 | 899 | 0.260 |
Why?
|
| Texas | 4 | 2019 | 3632 | 0.260 |
Why?
|
| Exanthema | 1 | 2008 | 74 | 0.260 |
Why?
|
| Young Adult | 7 | 2019 | 9966 | 0.250 |
Why?
|
| Antigens, Bacterial | 1 | 2008 | 324 | 0.250 |
Why?
|
| Mycoses | 1 | 2007 | 117 | 0.250 |
Why?
|
| Proton Pump Inhibitors | 3 | 2018 | 282 | 0.240 |
Why?
|
| Anti-HIV Agents | 1 | 2008 | 347 | 0.220 |
Why?
|
| Osteomyelitis | 1 | 2007 | 213 | 0.220 |
Why?
|
| Glucocorticoids | 2 | 2019 | 387 | 0.210 |
Why?
|
| Cytokines | 3 | 2021 | 1365 | 0.210 |
Why?
|
| Surveys and Questionnaires | 5 | 2020 | 3995 | 0.210 |
Why?
|
| Immunosuppressive Agents | 1 | 2008 | 673 | 0.210 |
Why?
|
| Immune Tolerance | 2 | 2021 | 153 | 0.200 |
Why?
|
| Erythema | 1 | 2023 | 29 | 0.200 |
Why?
|
| Biopsy | 4 | 2017 | 1288 | 0.200 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2017 | 305 | 0.200 |
Why?
|
| Immunophenotyping | 2 | 2021 | 343 | 0.190 |
Why?
|
| Gulf of Mexico | 1 | 2022 | 4 | 0.190 |
Why?
|
| Infant, Newborn | 7 | 2021 | 8548 | 0.180 |
Why?
|
| Antigens, CD | 2 | 2017 | 436 | 0.180 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2021 | 32 | 0.180 |
Why?
|
| Monensin | 2 | 2021 | 11 | 0.180 |
Why?
|
| Brefeldin A | 2 | 2021 | 11 | 0.180 |
Why?
|
| Urban Population | 2 | 2013 | 245 | 0.170 |
Why?
|
| Cell Proliferation | 1 | 2008 | 2510 | 0.170 |
Why?
|
| Esophagus | 2 | 2015 | 234 | 0.170 |
Why?
|
| Cross-Sectional Studies | 2 | 2020 | 3761 | 0.170 |
Why?
|
| Multigene Family | 1 | 2021 | 305 | 0.170 |
Why?
|
| Infant Formula | 1 | 2021 | 98 | 0.170 |
Why?
|
| Immunologic Factors | 3 | 2019 | 185 | 0.160 |
Why?
|
| Seafood | 1 | 2020 | 10 | 0.160 |
Why?
|
| Immunologic Memory | 1 | 2021 | 199 | 0.160 |
Why?
|
| Minority Groups | 1 | 2022 | 250 | 0.160 |
Why?
|
| Histamine Antagonists | 1 | 2019 | 17 | 0.160 |
Why?
|
| T-Lymphocytes | 1 | 2008 | 1757 | 0.160 |
Why?
|
| Health Facility Size | 1 | 2019 | 5 | 0.160 |
Why?
|
| Transdermal Patch | 1 | 2019 | 8 | 0.150 |
Why?
|
| Reflex, Pupillary | 1 | 2019 | 16 | 0.150 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2020 | 118 | 0.150 |
Why?
|
| Dendritic Cells | 1 | 2022 | 448 | 0.150 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2021 | 213 | 0.150 |
Why?
|
| Diagnostic Techniques, Digestive System | 1 | 2018 | 3 | 0.150 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2020 | 337 | 0.150 |
Why?
|
| Amino Acids | 1 | 2021 | 626 | 0.150 |
Why?
|
| Artemia | 1 | 2018 | 2 | 0.150 |
Why?
|
| Pyroglyphidae | 1 | 2018 | 7 | 0.150 |
Why?
|
| Antigens, Dermatophagoides | 1 | 2018 | 9 | 0.140 |
Why?
|
| Sex Distribution | 1 | 2019 | 327 | 0.140 |
Why?
|
| Age Distribution | 1 | 2019 | 437 | 0.140 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 347 | 0.140 |
Why?
|
| Self Administration | 1 | 2018 | 52 | 0.140 |
Why?
|
| Combined Modality Therapy | 3 | 2020 | 1294 | 0.140 |
Why?
|
| Gene-Environment Interaction | 1 | 2018 | 130 | 0.130 |
Why?
|
| Aged | 5 | 2021 | 21482 | 0.130 |
Why?
|
| Siblings | 1 | 2018 | 202 | 0.130 |
Why?
|
| Administration, Intravenous | 1 | 2017 | 162 | 0.130 |
Why?
|
| Vomiting | 1 | 2017 | 108 | 0.130 |
Why?
|
| Bixaceae | 1 | 2016 | 2 | 0.130 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 1161 | 0.130 |
Why?
|
| Health Policy | 1 | 2019 | 232 | 0.130 |
Why?
|
| ROC Curve | 1 | 2018 | 600 | 0.130 |
Why?
|
| Nitrosation | 1 | 2016 | 4 | 0.130 |
Why?
|
| Galectins | 1 | 2016 | 26 | 0.130 |
Why?
|
| Seeds | 1 | 2016 | 39 | 0.130 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2016 | 69 | 0.120 |
Why?
|
| Milk, Human | 1 | 2019 | 308 | 0.120 |
Why?
|
| Time Factors | 2 | 2021 | 6451 | 0.120 |
Why?
|
| Graft vs Host Disease | 2 | 2019 | 622 | 0.120 |
Why?
|
| Emergency Service, Hospital | 1 | 2024 | 1170 | 0.120 |
Why?
|
| Sensitivity and Specificity | 2 | 2018 | 2139 | 0.120 |
Why?
|
| Fluticasone-Salmeterol Drug Combination | 1 | 2015 | 9 | 0.120 |
Why?
|
| Itraconazole | 1 | 2015 | 24 | 0.120 |
Why?
|
| Cushing Syndrome | 1 | 2015 | 20 | 0.120 |
Why?
|
| Blood Proteins | 1 | 2016 | 136 | 0.120 |
Why?
|
| Budesonide | 1 | 2015 | 19 | 0.120 |
Why?
|
| Histoplasma | 1 | 2015 | 37 | 0.120 |
Why?
|
| Carotenoids | 1 | 2016 | 79 | 0.120 |
Why?
|
| Protein-Losing Enteropathies | 1 | 2015 | 19 | 0.120 |
Why?
|
| Middle Aged | 5 | 2021 | 29021 | 0.120 |
Why?
|
| Gastroenterology | 1 | 2018 | 211 | 0.120 |
Why?
|
| Risk Factors | 4 | 2015 | 10944 | 0.120 |
Why?
|
| Linear Models | 1 | 2017 | 714 | 0.120 |
Why?
|
| Diarrhea | 1 | 2017 | 331 | 0.120 |
Why?
|
| Bronchiectasis | 1 | 2015 | 22 | 0.120 |
Why?
|
| HIV Infections | 1 | 2008 | 2049 | 0.120 |
Why?
|
| Risk | 1 | 2017 | 761 | 0.120 |
Why?
|
| Histoplasmosis | 1 | 2015 | 55 | 0.110 |
Why?
|
| Plant Extracts | 1 | 2016 | 135 | 0.110 |
Why?
|
| Deglutition | 1 | 2015 | 60 | 0.110 |
Why?
|
| Critical Illness | 1 | 2019 | 618 | 0.110 |
Why?
|
| Transcriptome | 1 | 2021 | 1125 | 0.110 |
Why?
|
| Inflammation | 2 | 2014 | 1522 | 0.110 |
Why?
|
| Risk Assessment | 2 | 2019 | 3736 | 0.110 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2018 | 1671 | 0.110 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 2013 | 19 | 0.110 |
Why?
|
| Comorbidity | 1 | 2019 | 1610 | 0.110 |
Why?
|
| Goats | 1 | 2013 | 61 | 0.110 |
Why?
|
| Saliva | 1 | 2014 | 133 | 0.100 |
Why?
|
| Specimen Handling | 1 | 2014 | 151 | 0.100 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2016 | 286 | 0.100 |
Why?
|
| Sex Factors | 1 | 2017 | 1354 | 0.100 |
Why?
|
| Injections | 1 | 2013 | 152 | 0.100 |
Why?
|
| Blood Pressure | 1 | 2019 | 1402 | 0.100 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2013 | 84 | 0.100 |
Why?
|
| Prospective Studies | 3 | 2021 | 6568 | 0.100 |
Why?
|
| Biomarkers | 3 | 2020 | 3404 | 0.100 |
Why?
|
| Bronchodilator Agents | 1 | 2014 | 150 | 0.100 |
Why?
|
| Deglutition Disorders | 1 | 2015 | 146 | 0.100 |
Why?
|
| Sheep | 1 | 2013 | 229 | 0.100 |
Why?
|
| Dilatation | 1 | 2013 | 71 | 0.100 |
Why?
|
| Nitric Oxide | 1 | 2016 | 470 | 0.100 |
Why?
|
| Membrane Proteins | 1 | 2021 | 1597 | 0.100 |
Why?
|
| Physical Examination | 1 | 2013 | 165 | 0.090 |
Why?
|
| Phenotype | 1 | 2022 | 4540 | 0.090 |
Why?
|
| Esophagoscopy | 1 | 2013 | 168 | 0.090 |
Why?
|
| Social Class | 1 | 2013 | 207 | 0.090 |
Why?
|
| Proteomics | 1 | 2016 | 596 | 0.090 |
Why?
|
| Industry | 1 | 2012 | 29 | 0.090 |
Why?
|
| Retrospective Studies | 5 | 2019 | 17395 | 0.090 |
Why?
|
| Fetal Growth Retardation | 1 | 2013 | 254 | 0.090 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 3092 | 0.080 |
Why?
|
| Cattle | 1 | 2012 | 569 | 0.080 |
Why?
|
| Socioeconomic Factors | 1 | 2013 | 902 | 0.080 |
Why?
|
| Mites | 1 | 2009 | 4 | 0.080 |
Why?
|
| Administration, Cutaneous | 2 | 2020 | 67 | 0.080 |
Why?
|
| Cockroaches | 1 | 2009 | 6 | 0.080 |
Why?
|
| Dust | 1 | 2009 | 15 | 0.080 |
Why?
|
| Incidence | 1 | 2017 | 3376 | 0.080 |
Why?
|
| Eczema | 1 | 2009 | 31 | 0.080 |
Why?
|
| Aerosols | 1 | 2009 | 64 | 0.080 |
Why?
|
| Urticaria | 1 | 2009 | 22 | 0.080 |
Why?
|
| Angioedema | 1 | 2009 | 22 | 0.080 |
Why?
|
| Food, Formulated | 1 | 2019 | 38 | 0.080 |
Why?
|
| United States Food and Drug Administration | 2 | 2020 | 160 | 0.080 |
Why?
|
| Hypersensitivity, Immediate | 1 | 2019 | 17 | 0.080 |
Why?
|
| Enterotoxins | 2 | 2021 | 82 | 0.080 |
Why?
|
| CD4 Antigens | 1 | 2009 | 56 | 0.070 |
Why?
|
| Infant Food | 1 | 2019 | 74 | 0.070 |
Why?
|
| CD8 Antigens | 1 | 2009 | 45 | 0.070 |
Why?
|
| Immunoglobulin G | 2 | 2009 | 803 | 0.070 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2009 | 56 | 0.070 |
Why?
|
| Age Factors | 1 | 2015 | 2923 | 0.070 |
Why?
|
| Lymphocyte Count | 1 | 2008 | 120 | 0.070 |
Why?
|
| CD3 Complex | 1 | 2008 | 92 | 0.070 |
Why?
|
| Nutritional Requirements | 1 | 2019 | 160 | 0.070 |
Why?
|
| Transplantation Conditioning | 1 | 2009 | 302 | 0.070 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 7138 | 0.070 |
Why?
|
| Immunity, Cellular | 1 | 2008 | 203 | 0.070 |
Why?
|
| Voriconazole | 1 | 2007 | 34 | 0.070 |
Why?
|
| Lipopeptides | 1 | 2007 | 36 | 0.070 |
Why?
|
| Sacrum | 1 | 2007 | 31 | 0.070 |
Why?
|
| Reference Values | 1 | 2009 | 703 | 0.070 |
Why?
|
| HMGB1 Protein | 1 | 2007 | 26 | 0.070 |
Why?
|
| Peptides, Cyclic | 1 | 2007 | 52 | 0.070 |
Why?
|
| Echinocandins | 1 | 2007 | 44 | 0.070 |
Why?
|
| Lymphocyte Activation | 2 | 2021 | 686 | 0.060 |
Why?
|
| Treatment Outcome | 6 | 2020 | 13027 | 0.060 |
Why?
|
| Triazoles | 1 | 2007 | 147 | 0.060 |
Why?
|
| Forkhead Transcription Factors | 1 | 2009 | 387 | 0.060 |
Why?
|
| Antibodies, Bacterial | 1 | 2008 | 406 | 0.060 |
Why?
|
| Double-Blind Method | 2 | 2021 | 1653 | 0.060 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2009 | 449 | 0.060 |
Why?
|
| Prognosis | 2 | 2019 | 5016 | 0.060 |
Why?
|
| Antifungal Agents | 1 | 2007 | 314 | 0.060 |
Why?
|
| Pyrimidines | 1 | 2007 | 418 | 0.050 |
Why?
|
| Follow-Up Studies | 3 | 2020 | 5410 | 0.050 |
Why?
|
| Cells, Cultured | 2 | 2021 | 3045 | 0.050 |
Why?
|
| Synbiotics | 1 | 2021 | 5 | 0.040 |
Why?
|
| Predictive Value of Tests | 2 | 2018 | 2314 | 0.040 |
Why?
|
| Primary Cell Culture | 1 | 2021 | 107 | 0.040 |
Why?
|
| Pregnancy | 1 | 2013 | 7557 | 0.040 |
Why?
|
| Omalizumab | 1 | 2020 | 35 | 0.040 |
Why?
|
| International Cooperation | 1 | 2021 | 167 | 0.040 |
Why?
|
| Healthy Volunteers | 1 | 2021 | 152 | 0.040 |
Why?
|
| Pediatrics | 1 | 2009 | 1210 | 0.040 |
Why?
|
| Eggs | 1 | 2019 | 21 | 0.040 |
Why?
|
| Triticum | 1 | 2019 | 34 | 0.040 |
Why?
|
| Government Regulation | 1 | 2019 | 43 | 0.040 |
Why?
|
| Needles | 1 | 2019 | 53 | 0.040 |
Why?
|
| Policy Making | 1 | 2019 | 62 | 0.040 |
Why?
|
| Academies and Institutes | 1 | 2019 | 88 | 0.040 |
Why?
|
| Advisory Committees | 1 | 2019 | 151 | 0.040 |
Why?
|
| Confidence Intervals | 1 | 2019 | 277 | 0.040 |
Why?
|
| Ionomycin | 1 | 2017 | 18 | 0.030 |
Why?
|
| Histocytochemistry | 1 | 2017 | 92 | 0.030 |
Why?
|
| Comparative Effectiveness Research | 1 | 2017 | 72 | 0.030 |
Why?
|
| Administration, Topical | 1 | 2017 | 140 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2019 | 1050 | 0.030 |
Why?
|
| Skin | 1 | 2019 | 527 | 0.030 |
Why?
|
| Eating | 1 | 2019 | 381 | 0.030 |
Why?
|
| Remission Induction | 1 | 2017 | 306 | 0.030 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2020 | 559 | 0.030 |
Why?
|
| Endoscopy, Digestive System | 1 | 2017 | 157 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2008 | 2552 | 0.030 |
Why?
|
| Protein Transport | 1 | 2017 | 370 | 0.030 |
Why?
|
| Chimerism | 1 | 2015 | 29 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 1249 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2017 | 356 | 0.030 |
Why?
|
| Consensus | 1 | 2018 | 658 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2017 | 679 | 0.030 |
Why?
|
| Iatrogenic Disease | 1 | 2015 | 131 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2017 | 802 | 0.030 |
Why?
|
| Sialorrhea | 1 | 2014 | 16 | 0.030 |
Why?
|
| Drug Interactions | 1 | 2015 | 246 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2020 | 1036 | 0.030 |
Why?
|
| Weight Gain | 1 | 2015 | 381 | 0.020 |
Why?
|
| Logistic Models | 1 | 2017 | 1841 | 0.020 |
Why?
|
| Pedigree | 1 | 2015 | 1724 | 0.020 |
Why?
|
| Algorithms | 1 | 2018 | 1725 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 946 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2016 | 1034 | 0.020 |
Why?
|
| Immunoglobulin A | 1 | 2009 | 218 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 4687 | 0.020 |
Why?
|
| Genomics | 1 | 2016 | 1652 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 3018 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2009 | 1127 | 0.020 |
Why?
|
| Mice | 1 | 2019 | 18502 | 0.010 |
Why?
|